Crystal form of 1-chloro-4- (β-D-glucopyranos-1-yl) -2- (4-ethynyl-benzyl) -benzene, process for its preparation and their use for the manufacture of a medicament
The invention relates to a crystalline hydrate of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene and to crystalline complexes between 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene and a natural amino acid, to methods for the preparation thereof, as well as to uses thereof for preparing medicaments.